Revvity | Capital Y Las Reservas



Equity Capital And Reserves Cambio Fecha
Adcock Ingram Holdings ZAR 5.41B 63.09M 2024-06
Agilent USD 6.03B 129M 2025-01
Align Technology USD 3.85B 92.37M 2024-12
Bio Techne USD 2.08B 60.16M 2024-12
Bio-Rad Laboratories USD 6.57B 918.56M 2024-12
Bruker USD 1.8B 28M 2024-12
Celltrion KRW 16.89T 38.11B 2024-09
Charles River Laboratories USD 3.46B 320.77M 2024-12
Cspc Pharmaceutical CNY 34.85B 167.05M 2024-06
Danaher USD 49.54B 1.76B 2024-12
Dentsply International USD 1.94B 549M 2024-12
Dianthus Therapeutics USD 337.9M 20.32M 2024-09
Ecofibre AUD 40.97M 10.34M 2024-06
Edwards Lifesciences USD 10B 452.8M 2024-12
Exact Sciences USD 2.4B 808.26M 2024-12
Hologic USD 4.77B 356.7M 2024-12
Illumina USD 2.37B 248M 2024-12
Intuitive Surgical USD 16.53B 946.3M 2024-12
IQVIA Holdings USD 6.07B 900M 2024-12
Kangmei Pharma CNY 7.04B 22.02M 2024-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 482.76M 41.02M 2024-06
Laboratory Of America USD 8.05B 118M 2024-12
Malin Corporation EUR 118.2M 8.7M 2024-06
Medical Developments International AUD 45.73M 29.96M 2024-06
Mettler Toledo International USD -126890000 27.46M 2024-12
Myriad Genetics USD 701.1M 30.6M 2024-12
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organigram Holdings CAD 323.65M 17.66M 2024-12
Patterson Companies USD 989.56M 26.55M 2025-01
Pharma Mar EUR 208.36M 26.19M 2024-12
Qiagen NV USD 3.57B 37.35M 2024-12
Quest Diagnostics USD 6.78B 143M 2024-12
Quidel USD 2.98B 202.2M 2024-12
Repligen USD 2.02B 30.33M 2024-09
Revvity USD 7.67B 254.83M 2024-12
Sartorius EUR 3.78B 33.4M 2024-09
Sino Biopharmaceutical CNY 42.12B 3.95B 2024-06
Thermo Fisher Scientific USD 49.58B 592M 2024-12
Tilray USD 3.47B 5.16M 2024-11
Waters USD 1.83B 225.41M 2024-12
Zz Pientze Pharmaceu 14.02B 351.74M 2024-09



Revvity Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.